Philadelphia Chromosome-Positive Acute Myelocytic Leukemia With French-American-British M2 Morphology, Refractory to Tyrosine Kinase Inhibitors

Tenri Medical Bulletin
doi 10.12936/tenrikiyo.15.34
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Tenri Foundation, Tenri Institute of Medical Research

Related search

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2011English

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor

Cureus
2019English

Combination Therapy With Copanlisib and ABL Tyrosine Kinase Inhibitors Against Philadelphia Chromosome-Positive Resistant Cells

Oncotarget
Oncology
2016English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Correlation Between Deletion of the CDKN2 Gene and Tyrosine Kinase Inhibitor Resistance in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Upfront Treatment With the First and Second-Generation Tyrosine Kinase Inhibitors in Ph-Positive Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2017English

Philadelphia Chromosome‐negative Acute Leukemia in Chronic Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Lymphoblasts Expressing Surface IgM in the Absence of Kappa and Lambda in Philadelphia Positive Acute Lymphoblastic Leukemia: Philadelphia Chromosome Positive Transitional Pre-B Acute Lymphoblastic Leukemia

Clinical Case Reports and Reviews
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy